Manasrah Nouraldeen, Herath Chandima J, Al Sbihi Ali, Alqasem Sarah, Kao Andrew S, Chaudhary Ahmed J, Ismail Rana
DMC Sinai Grace Hospital, Detroit, MI, USA.
Eur J Case Rep Intern Med. 2022 Mar 28;9(3):003267. doi: 10.12890/2022_003267. eCollection 2022.
Obesity has become a major public health problem with increased prevalence and is associated with cardiovascular mortality. Phentermine is approved for short-term obesity treatment in conjunction with lifestyle modifications. Palpitations are a well-documented side effect of phentermine, but atrial fibrillation (AF) is rarely reported. We present a case of new-onset AF in a healthy woman who had been recently started on phentermine for weight loss.
Atrial fibrillation usually occurs secondary to intrinsic disorders such as hypertension, coronary artery disease, abnormal heart valves, thyroid dysfunction and medication side effects.Phentermine is used for a short period together with diet and exercise to treat obesity; atrial fibrillation is an unusual cardiovascular side effect of phentermine that warrants clinician caution.The importance of medication reconciliation is exemplified in this case as it is essential to rule out secondary causes of atrial fibrillation, including medication side effects.
肥胖已成为一个患病率不断上升的主要公共卫生问题,且与心血管疾病死亡率相关。苯丁胺被批准用于与生活方式改变相结合的短期肥胖治疗。心悸是苯丁胺一种有充分记录的副作用,但心房颤动(AF)鲜有报道。我们报告一例健康女性新发房颤病例,该女性最近开始服用苯丁胺以减轻体重。
心房颤动通常继发于诸如高血压、冠状动脉疾病、心脏瓣膜异常、甲状腺功能障碍和药物副作用等内在疾病。苯丁胺与饮食和运动一起短期用于治疗肥胖;心房颤动是苯丁胺一种不常见的心血管副作用,值得临床医生警惕。本病例体现了用药核对的重要性,因为排除心房颤动的继发原因(包括药物副作用)至关重要。